These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10427993)

  • 1. Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes.
    Boeckler C; Dautel D; Schelté P; Frisch B; Wachsmann D; Klein JP; Schuber F
    Eur J Immunol; 1999 Jul; 29(7):2297-308. PubMed ID: 10427993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination construct.
    Roth A; Rohrbach F; Weth R; Frisch B; Schuber F; Wels WS
    Br J Cancer; 2005 Apr; 92(8):1421-9. PubMed ID: 15812545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory.
    Gregoriadis G; Wang Z; Barenholz Y; Francis MJ
    Immunology; 1993 Dec; 80(4):535-40. PubMed ID: 7508417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes.
    Roth A; Espuelas S; Thumann C; Frisch B; Schuber F
    Bioconjug Chem; 2004; 15(3):541-53. PubMed ID: 15149182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of a CD4 T cell helper epitope via covalent liposome attachment with a surface-arrayed B cell target antigen fosters higher affinity antibody responses.
    Elbahnasawy MA; Donius LR; Reinherz EL; Kim M
    Vaccine; 2018 Oct; 36(41):6191-6201. PubMed ID: 30197285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design and immunogenicity of liposome-based diepitope constructs: application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen.
    Said Hassane F; Phalipon A; Tanguy M; Guerreiro C; Bélot F; Frisch B; Mulard LA; Schuber F
    Vaccine; 2009 Aug; 27(39):5419-26. PubMed ID: 19559116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes.
    Roehrig JT; Johnson AJ; Hunt AR; Beaty BJ; Mathews JH
    J Virol; 1992 Jun; 66(6):3385-90. PubMed ID: 1374807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and vaccine efficacy of synthetic peptides containing Semliki Forest virus B and T cell epitopes.
    Snijders A; Benaissa-Trouw BJ; Snippe H; Kraaijeveld CA
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2267-72. PubMed ID: 1383405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization.
    Shaw DM; Stanley CM; Partidos CD; Steward MW
    Mol Immunol; 1993 Aug; 30(11):961-8. PubMed ID: 7688851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cross-reactive antibodies against a self protein by immunization with a modified self protein containing a foreign T helper epitope.
    Dalum I; Jensen MR; Gregorius K; Thomasen CM; Elsner HI; Mouritsen S
    Mol Immunol; 1997; 34(16-17):1113-20. PubMed ID: 9566759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential reactivity of maleimide and bromoacetyl functions with thiols: application to the preparation of liposomal diepitope constructs.
    Schelté P; Boeckler C; Frisch B; Schuber F
    Bioconjug Chem; 2000; 11(1):118-23. PubMed ID: 10639094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of liposomal ErbB2/HER2 epitope peptide-based vaccine constructs incorporating TLR agonists and mannose receptor targeting.
    Thomann JS; Heurtault B; Weidner S; Brayé M; Beyrath J; Fournel S; Schuber F; Frisch B
    Biomaterials; 2011 Jul; 32(20):4574-83. PubMed ID: 21474175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-dominant and reciprocal T-helper cell activity of epitopic sequences and formation of junctional B-cell determinants in synthetic T:B chimeric immunogens.
    Sharma P; Kumar A; Batni S; Chauhan VS
    Vaccine; 1993 Oct; 11(13):1321-6. PubMed ID: 8296485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses.
    Guan HH; Budzynski W; Koganty RR; Krantz MJ; Reddish MA; Rogers JA; Longenecker BM; Samuel J
    Bioconjug Chem; 1998; 9(4):451-8. PubMed ID: 9667946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
    Franke ED; Corradin G; Hoffman SL
    J Immunol; 1997 Oct; 159(7):3424-33. PubMed ID: 9317141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.
    Azoury-Ziadeh R; Herd K; Fernando GJ; Frazer IH; Tindle RW
    Viral Immunol; 1999; 12(4):297-312. PubMed ID: 10630789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chemically defined synthetic vaccine model for HIV-1.
    Nardelli B; Lu YA; Shiu DR; Delpierre-Defoort C; Profy AT; Tam JP
    J Immunol; 1992 Feb; 148(3):914-20. PubMed ID: 1370524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic peptides coupled to the lipotripeptide P3CSS induce in vivo B and Thelper cell responses to HIV-1 reverse transcriptase.
    Loleit M; Ihlenfeldt HG; Brünjes J; Jung G; Müller B; Hoffmann P; Bessler WG; Pierres M; Haas G
    Immunobiology; 1996 Jan; 195(1):61-76. PubMed ID: 8852601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.